Herpes zoster in the immunocompromized populations

Indian Journal of Dermatology

Volumn 51, Issue 4, 2006, Pages 235-243

  Mandal, B ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846704234     PISSN: 00195154     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5154.30285     Document Type: Editorial

References (104)

1. Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
2. rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310-6.
3. Mazur MH, Whitley RJ, Dolin R. Serum antibody levels and risk factors in the dissemination of herpes zoster. Arch Int Med 1979;139:1341-5.
4. Groth KE, McCullough J, Marker SC, Howard RJ, Simmons RL, Najarian JS, et al. Evaluation of zoster immune plasma. JAMA 1978;239:1877-9.
5. Stevens DA, Merigan TC. Zoster immunoglobulin prophylaxis of disseminated zoster in compromised host: A randomised trial. Arch Int Med 1980;140:52-4.
6. Mandal BK. Herpes zoster in immunocompromized patients. Res Clin Forum 1986;8:39-49.
7. Mazur MH, Dolin R. Herpes zoster at the NIH: A 20 year experience. Am J Med 1978;65:738-44.
8. Williams HM, Diamond HD, Craver LF, et al. Neurological complications of lymphomas and leukaemias. Thomas CC, editor. Springfield: Illinois; 1959.
9. Feldman S, Hughes WT, Kim HY. Herpes zoster in children with cancer. Am J DIS Child 1973;126:178-84.
10. Schimpff S, Serpick A, Stoler B, Rumack B, Mellin H, Joseph JM, et al. Varicella-zoster infection in patients with cancer. Ann Int Med 1972;76:241-54.
11. Guinee VF, Guido JJ, Pfalzgraf KA, Giacco GG, Lagarde C, Durand M, et al. The incidence of herpes zoster in patients with Hodgkin's disease: An analysis of prognostic factors. Cancer 1985;56:642-8.
12. Ellis F, Stoll BA. Herpes zoster after irradiation. Br Med J 1949;2:1323-8.
13. Feld R, Evans WK, Deboer G. Herpes zoster in patients with small-cell carcinoma of the lung receiving combined modality treatment. Ann Int Med 1980;93:282-3.
14. Huberman M, Fossieck BE Jr, Bunn PA Jr, Cohen MH, Ihde DC, Minna JD. Herpes zoster and small cell bronchogenic carcinoma. Am J Med 1980;68:214-8.
15. Goffinet DR, Glatstein EJ, Merigan TC. Herpes zoster-varicella infections and lymphoma. Ann Int Med 1972;76:235-40.
16. Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB. Cutaneaous findings in chronic lymphocytic leukaemia. Br J Dermatol 2004;150:1129-35.
17. Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, et al. Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukaemia: Intergroup Study Cancer and Leukaemia Group. J Clin Oncol 2001;19:3611-21.
18. Annaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, et al. Infections in patients with chronic lymhocytic leukaemia treated with fludarabine. Ann Int Med 1998;129:559-66.
19. Thursky KA, Worth LJ, Seymour JF, Miles Prince H, Slavin MA. Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*. Br J Haematol 2006;132:3-12.
20. Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: Incidence, risk factors and complications. Bone Marrow Transplant 1994;13:277-83.
21. Atkinson K, Meyers JD, Storb R, Prentice RL, Thomas ED. Varicella-zoster virus infection after marrow transplantation for aplastic anaemia or leukaemia. Transplantation 1980;29:47-50.
22. Locksley RM, Fluornoy N, Sullivan KM, Meyers JD. Infection with varicella zoster virus after marrow transplantation. J Infect Dis 1985;152:1172-81.
23. Christiansen NP, Haake RJ, Hurd DD. Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant. Bone Marrow Transplant 1991;7:435-7.
24. st ed. Lippincott-Raven: Philadelphia; 1998. p. 265-86.
25. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004;4:108-15.
26. Hwang EA, Kang MJ, Han SY, Park SB, Kim HC. Viral infection following kidney transplantation: Long-term follow-up in a single centre. Transplant Proc 2004;36:2118-9.
27. Prakash J, Singh S, Prashant GK, Kar B, Tripathi K, Singh PB. Mucocutaneous lesions in transplant recipients in a tropical country. Transplant Proc 2004;36:2162-4.
28. Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, et al. Herpes zoster after liver transplantation: Incidence, risk factors and complications. Liver Transpl 2004;10:1140-3.
29. Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 1995;21:370-5.
30. Buchbinder SP, Katz MI, Hessol NA, Liu JY, O'Malley PM, Underwood R, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6.
31. Veenstra J, Krol A, van Praag RM, Frissen PH, Schellekens PT, Lange JM, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995;9:1153-8.
32. Morgan D, Mahe C, Malamba S, Okongo M, Mayanja B, Whitworth J. Herpes zoster and HIV infection in a rural Ugandan cohort. AIDS 2001;15:223-9.
33. Gebo KA, Kalyani R, Moore RD, Polydefkis MJ. The incidence of, risk factors for and sequelae of herpes zoster in highly active antiretroviral era. J Acquir Immune Defic Syndr 2005;40:169-74.
34. Hung CC, Hsiao CF, Wang JL, Chen MY, Hsieh SM, Sheng WH, et al. Herpes zoster in HIV-1 infected patients in the era of highly active antiretroviral therapy: A retrospective observational study. Int J STD AIDS 2005;16:673-6.
35. Lee PP, Lee TL, Hu MH, Wong WH, Lau YL. Herpes zoster in juvenile-onset systemic lupus erythematosus: Incidence, clinical characteristics and risk factors. Pediatr Infect Dis J 2006;25:728-32.
36. Moga I, Formiga F, Canet R, Pac M, Mitjavila F, Pujol R. Herpes-zoster virus infection in patients with systemic lupus erythematosus. Rev Clin Esp 1995;195:530-3.
37. Kang TY, Lee HS, Kim TH, Jun JB, Yoo DH. Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus. Rheumatol Int 2005;25:97-102.
38. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: Case-control study of patients with SLE or non-inflammatory musculoskeletal disorders. J Rheumatol 2004;31:274-9.
39. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995;22:1254-8.
40. Kahl LE. Herpes zoster infection in systemic lupus erythematosus: Risk factors and outcome. J Rheumatol 1994;21:84-6.
41. Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol 2004;31:2151-5.
42. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, et al. Herpes zoster in immunocompromised patients: Incidence, timing and risk factors. Am J Med 2005;118:1416.
43. Antonelli MA, Moreland LW, Brick JE. Herpes zoster in patients with rheumatoid arthritis with weekly, low dose methotrexate. Am J Med 1991;90:295-8.
44. Yamauchi Y, Nagasawa K, Tada Y, Tsukamoto H, Yoshizawa S, Mayumi T, et al. Herpes zoster in connective tissue diseases: II, in Rheumatoid arthritis and mixed connective tissue disease in comparison with systemic lupus erythematosus. Kansenshogaku Zasshi 1991;65:1389-93.
45. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000;136:999-1006.
46. Sofer NA, Fleischer AB Jr, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for treatment of atopic dermatitis in adult patients, part II, safety. J Am Acad Dermatol 2001;44:S39-46.
47. Fleischer AB Jr, Ling M, Eichenfeld L, Satoi Y, Jaracz E, Rico MJ, et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneaous infections. J Am Acad Dermatol 2002;47:562-70.
48. Dale DC, Fauci AS, Wolff SM. Alternate day prednisolone: Leukocyte kinetics and susceptibility to infection. N Eng J Med 1974;291:1154-8.
49. Steer CV, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogenic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 2000;25:657-64.
50. Villacian JS, Paya CV. Prevention of infection in solid organ transplant recipients. Transplant Infect Dis 1999;1:50-64.
51. World Health Organisation. Acquired Immunodeficiency Syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and diseases. Wkly Epidemiol Rec 1990;65:224.
52. Panda S, Sarkar S, Mandal BK, Singh TB, Singh KL, Mitra DK, et al. Epidemic of herpes zoster following HIV epidemic in Manipur, India. J Inf 1994;28:167-73.
53. Mandal BK. Editorial: Zoster and the immunocompromized. J Infect 1987;14:1-5.
54. Glesby MJ, Hoover DR, Tan T, Shi Q, Gao W, French AL, et al. Herpes zoster in women with and at risk for HIV: Data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004;37:1604-9.
55. Domingo P, Torres OH, Ris J, Vazquez G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type 1 infection. Am J Med 2001;110:605-9.
56. Price P, Mathiot N, Kruger R, Stone S, Keane NM, French MA. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001;22:279-87.
57. Handa S, Bingham JS. Dermatological immune restoration syndrome: Does it exist? J Eur Acad Dermatol Venereol 2001;15:430-2.
58. Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allerg Clin Immunol 2004;113:742-6.
59. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004;18:1615-7.
60. Clark BM, Kruger RG, Price P, French MA. Compartmentalisation of the immune response in varicella zoster virus immune restoration disease causing tranverse myelitis. AIDS 2004;18:1218-21.
61. Duni I, Djurkovi-Djakovi O, Vesi S, Zerjav S, Jevtovic D. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int J STD AIDS 2005;16:475-8.
62. Ratnam I, Chiu C, Kandal NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-27.
63. Ljungman P, Lonnqvist B, Gahrton G, Ringden O, Sundqvist VA, Wahren B. Clinical and subclinical reactivation of varicella-zoster virus in immunocompromized patients. J Infect Dis 1986;153:840-7.
64. Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of caricella-zoster virus infections in renal transplant patients. J Infect Dis 1977;135:659-63.
65. Au WY, Ma SY, Cheng VC, Ooi CG, Lie AK. Disseminated zoster, hyponatraemia, severe abdominal pain and leukaemia relapse: Recognition of a new clinical quartet after bone marrow transplantation. Br J Dermatol 2003;149:862-5.
66. Rogers SY, Irving W, Harris A, Russell NH. Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 1995;15:805-7.
67. Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992;165:119-26.
68. Sokal JE, Firat D. Varicella-zoster infection in Hodgkin's disease. Am J Med 1965;39:452-63.
69. Roseberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 1961;40:31-84.
70. th ed. (International Edition). Fauci AS, et al, editors. 1998. p. 1086-9.
71. Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden DH. The vasculopathy of varicella-zoster encephalitis. Ann Neurol 1995;37:784-90.
72. Gray F, Belec L, Lescs MC, Chretien F, Ciardi A, Hassine D, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994;117:987-99.
73. Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B. The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol 2002;8:75-9.
74. Hackanson B, Zeiser R, Bley TA, Pantazis G, Huzly D, Bertz H, et al. Fatal varicella zoster virus encephalitis in two patients following allogenic hematopoietc stem cell transplantation. Clin Transplant 2005;19:566-70.
75. Sciller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogenic bone marrow transplantation. Bone Marrow Transplant 1991;7:489-91.
76. Verdonck LF, Cornelissen JJ, Dekker AW, Rozenberg-Arska M. Acute abdominal pain as a presenting symptom of herpes zoster virus infection in recipients of bone marrow transplants. Clin Infect Dis 1993;16:190-1.
77. Leena M, Ville V, Veli-Jukka A. Visceral varicella zoster virus infection after stem cell transplantation: A possible cause of severe abdominal pain. Scan J Gastroenterol 2006;41:242-4.
78. Hyland JM, Butterworth J. Severe acute visceral pain from varicella zoster virus. Anaesth Analg 2003;97:1117-8.
79. Itoh M, Kawaguchi S, Yago K, Shimada H, Muro H. Acute abdominal pain preceding cutaneous manifestations of varicella zoster infection after allogenic bone marrow transplantation. Tohoku J Exp Med 2001;195:61-3.
80. Stratmen E. Visceral zoster as the presenting feature of disseminated herpes zoster. J Am Acad Dermatol 2002;46:771-4.
81. O'Loughlin CJ, Karnam US, Barkin JS. Visceral varicella zoster after bone marrow transplantation: an obscure cause of an "acute abdomen". Dig Dis Sci 2002;47:1962-4.
82. Berman JN, Wang M, Berry W, Neuberg DS, Guinan EC. Herpes zoster infection in the post-hematopoietic stem-cell transplant pediatric population may be preceded by transaminitis: An institutional experience. Bone Marrow Transplant 2006;37:73-80.
83. Holland GN. The progressive outer retinal necrosis syndrome. Int Opthalmol 1994;18:163-5.
84. Engstrom RE Jr, Holland GN, Margolis TP, Muccioli C, Lindley JI, Belfort R Jr, et al. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994;101:1488-502.
85. Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. Human leucocyte interferon for the treatment of herpes zoster in patients with cancer. N Eng J Med 1978;298:981-7.
86. Whitley RJ. Varicella-zoster virus infection. In: Galasso G, Merigan T, Buchanan R, editors. Antiviral Agents and Viral Infections of Man. Raven Press: New York; 1984. p. 317-41.
87. LeBoit PE, Limova M, Yen TS, Palefsky JM, White CR Jr, Berger TG. Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndrome (AIDS). Histologic and molecular biologic findings. Am J Dermatopathol 1992;14:1-7.
88. Leibovitz E, Kaul A, Rigaud M, Bebenroth D, Krasinski K, Borkowsky W. Chronic varicella zoster in a child infected with human immunodeficiency virus: A case report and review of the literature. Cutis 1992;49:27-31.
89. Siwamogstham P, Kuansuwan C, Reichart PA. Herpes zoster in HIV infection with osteonecrosis of the jaw and tooth exfoliation. Oral Dis 2006;12:500-5.
90. Nicoll S, Brass A, Cubie HA. Detection of herpes viruses in clinical samples using real-time PCR. J Virol Methods 2001;96:25-31.
91. de Jong MD, Weel JF, van Oers MH, Boom R, Wertheim-van Dillen PM. Molecular diagnosis of visceral herpes zoster. Lancet 2001;357:2101-2.
92. Ishizaki Y, Tezuka J, Ohga S, Nomura A, Suga N, Kuromaru R, et al. Quantification of circulating varicella zoster virus DNA for the early diagnosis of visceral varicella. J Infect 2003;47:133-8.
93. Balfour HH Jr. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med 1988;85:68-73.
94. Bidault R, Ducher A, Fusseau E, et al. Population pharmacokinetics and pharmacodynamic analysis of oral valacyclovir and intravenous acyclovir in immunocompromized patients for the treatment of herpes zoster. Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy: Washington DC; October 30-November 2. 2004. Abstract V -771.
95. Gnann JW Jr, Crumpacker CS, Lalezari JP, Smith JA, Tyring SK, Baum KF, et al. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: Results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother 1998;42:1139-45.
96. Reusser P. Herpesvirus resistance to antiviral drugs: A reviw of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996;33:235-48.
97. Masaoka T, Hiraoka A, Teshmina H, Tominaga N. Varicella-zoster virus infection in immunocompromized patients. J Med Virol 1993;1:82-4.
98. Hennekens CH, Buring JE. Measures of disease frequency. In: Maryland SL, editor. Epidemiology in Medicine. Little, Brown and Company: Boston; 1987. p. 54-98.
99. Thompson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogenic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005;35:1065-9.
100. Boeckh M, Kim HW, Flower ME, Meyers JD, Bowden RA. Long-term acyclovir for prevention of varicella zoster virus disease after allogenic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood 2006;107:1800-5.
101. Slifkin M, Doron S, Snydman DR. Viral prophylaxis in organ transplant patients. Drugs 2004;64:2763-92.
102. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Eng J Med 2005;352:2271-84.
103. rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois: September 14-17, 2003. Abstract G-1083.
104. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Eng J Med 2002;347:26-34.